90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial. (Q44762135)
Jump to navigation
Jump to search
scientific article published in April 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | 90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial. |
scientific article published in April 2013 |
Statements
90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial (English)
Achiel Van Hoof
Franck Morschhauser
Barbara Botto
Ama Z S Rohatiner
Herve Tilly
Angelika Bischof-Delaloye
Wim L J van Putten
Jelle W Kylstra
Anton Hagenbeek